Atlas Trials

PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor

Clinical trial NCT06014385 · WITHDRAWN

Trial details

NCT number
NCT06014385
Sponsor
Yale University
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Muscarinic Receptor Occupancy
Start date
2025-03-01
Primary completion
2025-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.